Carlyle-backed animal health company SeQuent Scientific and Viyash Life Sciences have announced a Rs 8,000 crore merger to create a platform that will be one of the largest in the animal pharmaceuticals space in India. Analysts feel that the combined entity will be better placed to tap the global markets for animal pharmaceuticals. The combined entity will have access to global markets (over 150 countries) with strong R&D, intellectual property, and product development capabilities, and 16 state-of-the-art manufacturing facilities. The combined entity will also have a more robust financial profile.
Read the full article: Carlyle-Backed SeQuent Scientific and Viyash Merge to Aid Global Ambitions //
Source: https://www.business-standard.com/companies/news/carlyle-backed-sequent-scientific-and-viyash-merger-to-aid-global-ambitions-124092701063_1.html